Regeneron and its partner Sanofi announced positive results in the first trial of their extensive Phase III ODYSSEY program (12 trials in total) for alirocumab (REGN-727), which targets PCSK9 to lower LDL (or “bad”) cholesterol. Alirocumab showed a 47.2% reduction in LDL levels from baseline over 24 weeks in patients with primary hypercholesterolemia and moderate…
According to decision-makers of the game-giant, Nintendo's emblematic figurse, such as Super Mario will not ever get on tablets. However, Nintendo plans to move on mobile devices, providing a well-known experience for users.Read More >>
Motorola is planning to make custom-build smartphones into reality. The new device is made of block, which enables the user to make the phone of their dreams.Read More >>
Shares of Twenty-First Century Fox (NASDAQ:FOXA) saw a large increase in short interest in the month of October. As of October 15th, there was short interest totalling 69,185,883 shares, an increase of 3.5% from the September 30th total of 66,858,523 shares, Stock Ratings Network reports. Approximately 5.0% of the shares of the company are short…
IAMGOLD Corp. (NYSE:IAG) had its price target trimmed by TD Securities from C$4.00 to C$3.50 in a research report sent to investors on Tuesday morning. The firm currently has a hold rating on the stock. IAMGOLD Corp. (NYSE:IAG) in last trading activity fell -4.68% to close at $2.24. Company weekly performance is -3.45% while its…
Shield, he new ware of Nvidia gives the users the experience of gaming at home. The portable device works with Android games. Its new contorller might enable users to play with Angry Birds and NBA games too.Read More >>
